Stock ACRS ACLARIS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Aclaris Therapeutics, Inc.

Equities

ACRS

US00461U1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-15 pm EDT 		5-day change 1st Jan Change
1.21 USD 0.00% Intraday chart for Aclaris Therapeutics, Inc. +1.68% +15.24%
Mar. 19 Aclaris Therapeutics, Inc. Announces Board Resignations CI
Feb. 27 Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aclaris Therapeutics, Inc. Announces Board Resignations
CI
Aclaris: Q4 Earnings Snapshot
AQ
Aclaris Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Aclaris Therapeutics, Inc. Announces Intangible Asset Impairment for the Three Months Ended December 31, 2023
CI
Earnings Flash (ACRS) ACLARIS THERAPEUTICS Posts Q4 Revenue $17.6M
MT
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
AQ
Aclaris Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
North American Morning Briefing : Stock Futures -2-
DJ
Aclaris Therapeutics, Inc. Announces Termination of Employment of Gail Cawkwell as Chief Medical Officer
CI
North American Morning Briefing : Stock Futures -2-
DJ
HC Wainwright Downgrades Aclaris Therapeutics to Neutral From Buy
MT
Sector Update: Health Care Stocks Weaker Late Afternoon
MT
Sector Update: Health Care Stocks Softer Tuesday Afternoon
MT
Aclaris Therapeutics Shares Rise; Strategic Review Announced, CEO Manion to Step Down
MT
Aclaris Therapeutics Conducts Strategic Review of Business
CI
Aclaris Therapeutics Announces Leadership Changes and Strategic Business Review
AQ
Aclaris Therapeutics, Inc. Announces Executive Changes
CI
Aclaris Therapeutics, Inc. Announces Chief Executive Officer Changes
CI
North American Morning Briefing : Stock Futures -2-
DJ
BTIG Downgrades Aclaris Therapeutics to Neutral From Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACRS Stock
  4. News Aclaris Therapeutics, Inc.